Severe Abdominal Pain Associated with Allergic Reaction to Nafamostat Mesilate in a Chronic Hemodialysis Patient.
-
- YAMAZATO Masanobu
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- MANO Rieko
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- OSHIRO-CHINEN Saori
- Dialysis Unit, University of the Ryukyus, School of Medicine
-
- TOMIYAMA Nozomi
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- SAKIMA Atsushi
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- ISHIDA Akio
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- TANA Takeshi
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- TOZAWA Masahiko
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- MURATANI Hiromi
- The Third Department of Internal Medicine, University of the Ryukyus, School of Medicine
-
- ISEKI Kunitoshi
- Dialysis Unit, University of the Ryukyus, School of Medicine
-
- TAKISHITA Shuichi
- Dialysis Unit, University of the Ryukyus, School of Medicine
この論文をさがす
抄録
A 33-year-old woman was referred from an outside dialysis clinic to our hospital because of severe abdominal pain during hemodialysis. She had been on chronic hemodialysis for the past 11 years due to chronic glomerulonephritis. Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea. On admission, she had no abdominal pain or gynecological abnormalities. On the second day, she had similar abdominal pain during hemodialysis with nafamostat mesilate in our dialysis unit. The abdominal pain disappeared within 60 minutes after discontinuing the hemodialysis. We re-started dialysis using heparin instead of nafamostat mesilate and she had no symptoms. The titer of total immunoglobulin E was high. The drug lymphocyte stimulation test was positive for nafamostat mesilate and antigen specific immunoglobulin E to nafamostat mesilate was highly positive in her blood. Although an allergic reaction to nafamostat mesilate is a rare complication, it should be one of the differential diagnoses of abdominal pain occurring during hemodialysis.<br>(Internal Medicine 41: 864-866, 2002)
収録刊行物
-
- Internal Medicine
-
Internal Medicine 41 (10), 864-866, 2002
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204867184768
-
- NII論文ID
- 130000767505
- 50000681081
-
- NII書誌ID
- AA10827774
-
- COI
- 1:STN:280:DC%2BD38nltFOmsw%3D%3D
-
- ISSN
- 13497235
- 09182918
-
- NDL書誌ID
- 6339918
-
- PubMed
- 12413011
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可